Company Analysis

Celularity Inc. (CELU)

Nasdaq: CELU · Pharmaceutical Preparations · Florham Park, NJ · filing with the SEC since 2018
Grade3.4
◀ Past 3.8● Present 3.6▶ Future 2.7
1 est.

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Report filedApr 30, 2026May 8, 2025Jul 30, 2024Mar 31, 2023Mar 31, 2022Mar 4, 2021Mar 24, 2020
Revenue26,550,00054,220,00022,771,00017,975,00021,335,00014,278,000·
Cost of revenue20,074,00014,989,00016,016,000····
Gross profit··6,755,000-1,690,00011,682,0009,346,000·
Research and development15,025,00017,386,00030,465,00078,363,00088,353,00052,707,000·
Selling, general and administrative51,266,00058,643,00050,576,00066,021,00071,341,00031,336,000·
Total costs and expenses·····4,219,9601,683,540r
Operating income-61,308,000-38,358,000-192,287,000-25,600,000-109,059,000-151,925,000r-1,683,540r
Interest and investment income·····1,779,0713,753,411
Other income (expense), net·1,560,000118,001,000····
Total non-operating income (expense)-30,405,000-19,534,000-3,998,00039,805,0008,961,000-61,008,000r8,230,540r
Income before income taxes-91,713,000-57,892,000-196,285,00014,205,000-100,098,000-212,933,000r6,547,000r
Income tax expense3,000·10,00013,00020,000-4,700,000r668,230
Income from continuing operations-61,308,000-38,358,000-192,287,000-25,600,000-109,058,000-151,925,000-772,682
Net income including non-controlling interests··-196,295,00014,192,000-100,118,000-208,233,000·
Net income-91,716,000-57,892,000-196,295,00014,192,000-100,118,000-208,233,000r5,878,770r
Net income to common shareholders-91,800,000-57,892,000···-3,930,141-217,549
Earnings per share, basic-3.59-2.64-11.021.01r-14.90b··
Earnings per share, diluted-3.59-2.64-11.020.95r-14.90b··
Earnings per share, basic and diluted····-14.90b-113.10rb1.00rb
Weighted average shares, basic25,598,58621,890,51817,813,04413,990,703r6,705,728b··
Weighted average shares, diluted25,598,58621,890,51817,813,04414,983,002r6,705,728b··
Weighted average shares, basic and diluted····6,705,728b1,841,791rb2,552,930rb
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-10 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfRevenue
Gross profit revenue less the cost of what it soldus-gaap:GrossProfit
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
Total costs and expenses every operating cost, the cost of revenue includedus-gaap:OperatingCostsAndExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Income from continuing operations profit from the businesses it keepsus-gaap:IncomeLossFromContinuingOperations
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton CELU · research, not advice